UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy

Journal of clinical oncology, 2010-01, Vol.28 (3), p.375-379

2010

Volltextzugriff (PDF)

Neoadjuvant chemotherapy with dose dense MVAC is associated with improved survival after radical cystectomy compared to other cytotoxic regimens: A tertiary center experience

PloS one, 2021-11, Vol.16 (11), p.e0259526-e0259526

2021

Volltextzugriff (PDF)

Risk of Breast Cancer in Women With a CHEK2 Mutation With and Without a Family History of Breast Cancer

Journal of clinical oncology, 2011-10, Vol.29 (28), p.3747-3752

2011

Volltextzugriff (PDF)

Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis

The lancet oncology, 2015-06, Vol.16 (6), p.638-644

2015

Volltextzugriff (PDF)

Ten-Year Survival in Patients With BRCA1-Negative and BRCA1-Positive Breast Cancer

Journal of clinical oncology, 2013-09, Vol.31 (26), p.3191-3196

2013

Volltextzugriff (PDF)

Chemotherapy-Induced Amenorrhea in Patients With Breast Cancer With a BRCA1 or BRCA2 Mutation

Journal of clinical oncology, 2013-11, Vol.31 (31), p.3914-3919

2013

Volltextzugriff (PDF)

Do founder mutations characteristic of some cancer sites also predispose to pancreatic cancer?

International journal of cancer, 2016-08, Vol.139 (3), p.601-606

2016

Volltextzugriff (PDF)

Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor

Hereditary cancer in clinical practice, 2022-03, Vol.20 (1), p.11-11, Article 11

2022

Volltextzugriff (PDF)

A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland

Breast cancer research and treatment, 2007-03, Vol.102 (1), p.119-122

2007

Volltextzugriff (PDF)

The RAD51 135 G>C Polymorphism Modifies Breast Cancer and Ovarian Cancer Risk in Polish BRCA1 Mutation Carriers

Cancer epidemiology, biomarkers & prevention, 2007-02, Vol.16 (2), p.270-275

2007

Volltextzugriff (PDF)

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

The lancet oncology, 2017-09, Vol.18 (9), p.1274-1284

2017

Volltextzugriff (PDF)

Variant alleles of the CYP1B1 gene are associated with colorectal cancer susceptibility

BMC cancer, 2010-08, Vol.10 (1), p.420-420, Article 420

2010

Volltextzugriff (PDF)

Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial

The lancet oncology, 2021-05, Vol.22 (5), p.620-631

2021

Volltextzugriff (PDF)

CHEK2-Positive Breast Cancers in Young Polish Women

Clinical cancer research, 2006-08, Vol.12 (16), p.4832-4835

2006

Volltextzugriff (PDF)

Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer

Breast cancer research : BCR, 2012-07, Vol.14 (4), p.R110-R110, Article R110

2012

Volltextzugriff (PDF)

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

JAMA : the journal of the American Medical Association, 2015-04, Vol.313 (13), p.1347

2015

Volltextzugriff (PDF)

Cisplatin in breast cancer treatment in BRCA1 carriers

Hereditary cancer in clinical practice, 2012-12, Vol.10 (Suppl 4), p.A17-A17

2012

Volltextzugriff (PDF)

The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers

British journal of cancer, 2012-12, Vol.107 (12), p.2005-2009

2012

Volltextzugriff (PDF)

Epistatic Relationship between the Cancer Susceptibility Genes CHEK2 and p27

Cancer epidemiology, biomarkers & prevention, 2007-03, Vol.16 (3), p.572-576

2007

Volltextzugriff (PDF)

Germline RECQL mutations are associated with breast cancer susceptibility

Nature genetics, 2015-06, Vol.47 (6), p.643-646

2015

Volltextzugriff (PDF)

Breast Cancer Risk Reduction Associated with the RAD51 Polymorphism among Carriers of the BRCA1 5382insC Mutation in Poland

Cancer epidemiology, biomarkers & prevention, 2003-05, Vol.12 (5), p.457-459

2003

Volltextzugriff (PDF)

Male to female ratio among offspring of BRCA1 mutation carriers

Breast cancer research and treatment, 2006-05, Vol.97 (1), p.113-114

2006

Volltextzugriff (PDF)

Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study

British journal of cancer, 2014-01, Vol.110 (2), p.530-534

2014

Volltextzugriff (PDF)

Prevalence of the NOD2 3020insC mutation in aggregations of breast and lung cancer

Breast cancer research and treatment, 2006-01, Vol.95 (2), p.141-145

2006

Volltextzugriff (PDF)

1 – 25 von 161

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(156)
Mit Volltextzugriff
(146)

Publikationsform

Sprache

Englisch
(158)
Polnisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy

Neoadjuvant chemotherapy with dose dense MVAC is associated with improved survival after radical cystectomy compared to other cytotoxic regimens: A tertiary center experience

Risk of Breast Cancer in Women With a CHEK2 Mutation With and Without a Family History of Breast Cancer

Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis

Ten-Year Survival in Patients With BRCA1-Negative and BRCA1-Positive Breast Cancer

Chemotherapy-Induced Amenorrhea in Patients With Breast Cancer With a BRCA1 or BRCA2 Mutation

Recurrent Mutations in BRCA1 , BRCA2 , RAD51C , PALB2 and CHEK2 in Polish Patients with Ovarian Cancer

Do founder mutations characteristic of some cancer sites also predispose to pancreatic cancer?

Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor

A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland

The RAD51 135 G>C Polymorphism Modifies Breast Cancer and Ovarian Cancer Risk in Polish BRCA1 Mutation Carriers

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

Variant alleles of the CYP1B1 gene are associated with colorectal cancer susceptibility

Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial

CHEK2-Positive Breast Cancers in Young Polish Women

Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

Cisplatin in breast cancer treatment in BRCA1 carriers

The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers

Epistatic Relationship between the Cancer Susceptibility Genes CHEK2 and p27

Germline RECQL mutations are associated with breast cancer susceptibility

Breast Cancer Risk Reduction Associated with the RAD51 Polymorphism among Carriers of the BRCA1 5382insC Mutation in Poland

Male to female ratio among offspring of BRCA1 mutation carriers

Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study

Prevalence of the NOD2 3020insC mutation in aggregations of breast and lung cancer

Suchergebnisse filtern